Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann W Morgan

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Pharmacogenomics|May 17, 2016
Previously reported PDE3A-SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohortSamantha Louise Smith, Darren Plant, Xiu Hue Lee, et al.
The Lancet. Infectious Diseases|March 4, 2021
Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort studyMichael Drozd, Mar Pujades-Rodriguez, Patrick J Lillie, et al.
Journal of Autoimmunity|May 26, 2024
Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigueJulia E Manning, Emma Harris, Hannah Mathieson, et al.
Annals of the Rheumatic Diseases|May 7, 2010
Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatmentRachael J L Tan, Laura J Gibbons, Catherine Potter, et al.
Arthritis Research & Therapy|October 9, 2012
Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohortDarren Plant, Ibrahim Ibrahim, Mark Lunt, et al.
Rheumatology and Immunology Research|July 3, 2025
Predicting response to infliximab and interferon-α in Behçet's syndrome: An exploratory analysis from the BIO-BEHÇET'S randomized controlled trialRobert J Moots, Farida Fortune, Richard Jackson, et al.
Arthritis Care & Research|December 17, 2013
Impact of psychological factors on subjective disease activity assessments in patients with severe rheumatoid arthritisLis Cordingley, Rita Prajapati, Darren Plant, et al.
Pharmacogenetics and Genomics|March 20, 2010
Polymorphisms spanning the TNFR2 and TACE genes do not contribute towards variable anti-TNF treatment responseCatherine Potter, Laura J Gibbons, John D Bowes, et al.
Rheumatology (Oxford, England)|September 13, 2014
Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohortJames Bluett, Catharine Morgan, Layla Thurston, et al.
Pharmacogenetics and Genomics|March 6, 2009
Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patientsJohn D Bowes, Catherine Potter, Laura J Gibbons, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Pharmacogenomics|May 17, 2016
Previously reported PDE3A-SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohortSamantha Louise Smith, Darren Plant, Xiu Hue Lee, et al.
The Lancet. Infectious Diseases|March 4, 2021
Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort studyMichael Drozd, Mar Pujades-Rodriguez, Patrick J Lillie, et al.
Journal of Autoimmunity|May 26, 2024
Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigueJulia E Manning, Emma Harris, Hannah Mathieson, et al.
Annals of the Rheumatic Diseases|May 7, 2010
Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatmentRachael J L Tan, Laura J Gibbons, Catherine Potter, et al.
Arthritis Research & Therapy|October 9, 2012
Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohortDarren Plant, Ibrahim Ibrahim, Mark Lunt, et al.
Rheumatology and Immunology Research|July 3, 2025
Predicting response to infliximab and interferon-α in Behçet's syndrome: An exploratory analysis from the BIO-BEHÇET'S randomized controlled trialRobert J Moots, Farida Fortune, Richard Jackson, et al.
Arthritis Care & Research|December 17, 2013
Impact of psychological factors on subjective disease activity assessments in patients with severe rheumatoid arthritisLis Cordingley, Rita Prajapati, Darren Plant, et al.
Pharmacogenetics and Genomics|March 20, 2010
Polymorphisms spanning the TNFR2 and TACE genes do not contribute towards variable anti-TNF treatment responseCatherine Potter, Laura J Gibbons, John D Bowes, et al.
Rheumatology (Oxford, England)|September 13, 2014
Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohortJames Bluett, Catharine Morgan, Layla Thurston, et al.
Pharmacogenetics and Genomics|March 6, 2009
Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patientsJohn D Bowes, Catherine Potter, Laura J Gibbons, et al.
Pageof 14